Publication | Open Access
FIGHT-202: A phase II study of pemigatinib in patients (pts) with previously treated locally advanced or metastatic cholangiocarcinoma (CCA)
59
Citations
0
References
2019
Year
Gastrointestinal OncologyMedicineHepatobiliary TumorBiliary CancerPhase Ii StudyPathologyCancer TreatmentMetastatic CholangiocarcinomaOncologyRadiation Oncology
No additional data available for this publication yet. Check back later!